Bromfenac
Generic Name: bromfenac
Brand Names:
Bromsite 0.075%
Bromfenac ophthalmic solution 0.075% is a sterile topical NSAID indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Overview
Bromfenac ophthalmic solution 0.075% is a sterile topical NSAID indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Uses
Indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Dosage
Apply one drop to the affected eye twice daily (morning and evening) starting 1 day before surgery, continuing surgery day, and for 14 days after.
Side Effects
Most commonly reported adverse reactions (1-8%) were anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, and ocular hypertension.
Warnings
Warnings regarding slow or delayed healing, cross-sensitivity potential, increased bleeding time, keratitis and corneal effects, and contact lens wear restrictions. No specific contraindications listed.
Pregnancy
Use during late pregnancy should be avoided due to prostaglandin biosynthesis-inhibiting drug effects on the fetal cardiovascular system.
Storage
Store at 15 to 25 degrees C (59 to 77 degrees F).
Frequently Asked Questions
What is Bromfenac used for?▼
Indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
What are the side effects of Bromfenac?▼
Most commonly reported adverse reactions (1-8%) were anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, and ocular hypertension.
Can I take Bromfenac during pregnancy?▼
Use during late pregnancy should be avoided due to prostaglandin biosynthesis-inhibiting drug effects on the fetal cardiovascular system.
What are the important warnings for Bromfenac?▼
Warnings regarding slow or delayed healing, cross-sensitivity potential, increased bleeding time, keratitis and corneal effects, and contact lens wear restrictions. No specific contraindications listed.
Related Medications
Tree Mix 5
tree mix 5
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ACER NEGUNDO POLLEN (.017 g/mL); ACER RUBRUM POLLEN (.017 g/mL); ACER SACCHARUM POLLEN (.017 g/mL); CARYA ILLINOINENSIS POLLEN (.05 g/mL); PLATANUS OCCIDENTALIS POLLEN (.05 g/mL); QUERCUS ALBA POLLEN (.017 g/mL); QUERCUS RUBRA POLLEN (.017 g/mL); QUERCUS VIRGINIANA POLLEN (.017 g/mL); SALIX NIGRA POLLEN (.05 g/mL). Category: BLA.
Sinapis Arvensis, Flos
sinapis arvensis, flos
INDICATIONS: For temporary relief of "dark cloud" that descends, making one saddened and low for no known reason.
Nemolizumab-ilto
nemolizumab-ilto
Interleukin-31 Receptor alpha Antagonist [EPC]
11 DESCRIPTION Nemolizumab-ilto, an interleukin-31 receptor alpha (IL-31RA) antagonist, is a humanized monoclonal modified immunoglobulin G (IgG) antibody with a molecular weight of approximately 144 kDa. Nemolizumab-ilto is produced by recombinant DNA technology in Chinese Hamster Ovary cells. NEMLUVIO (nemolizumab-ilto) for injection is a sterile, preservative-free, white lyophilized powder in a dualchamber, single-dose, prefilled pen for subcutaneous use.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.